Bernstein believes the biggest factor for IPO appetite is post-listing performance. This year, the average return from investing in IPOs is 3.7%. While that’s an improvement from the negative 7% ...
On CNBC's "Mad Money Lightning Round," Jim Cramer said AbbVie Inc. (NYSE:ABBV) is doing "very, very well." However, he added that Abbott Laboratories (NYSE:ABT) remains his favorite in the group right ...